ReviewMolecules (Basel, Switzerland)2018
'
Review in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 21 citations in OpenAlex.
- Regulatory mechanism of O-linked N-acetylglucosamine protein modification on autophagy in cancer.Clinical and translational medicine · 2026Review
- OGT Binding Peptide-Tagged Strategy Increases Protein O-GlcNAcylation Level inMolecules (Basel, Switzerland) · 2023Article
- ProteinMetabolites · 2022Review
- Article
- Article
- YM155 Inhibits NleB and SseK Arginine Glycosyltransferase Activity.Pathogens (Basel, Switzerland) · 2021Article
- Lactosyl-sepharose binding proteins from pancreatic cancer cells show differential expression in primary and metastatic organs.Experimental biology and medicine (Maywood, N.J.) · 2020Article
- Functional Analysis ofFrontiers in oncology · 2020Review
- Article
- Functional Roles ofMolecules (Basel, Switzerland) · 2018Article
- High-Throughput Screening for Bacterial Glycosyltransferase Inhibitors.Frontiers in cellular and infection microbiology · 2018Article
- Global profiling of O-GlcNAcylated and/or phosphorylated proteins in hepatoblastoma.Signal transduction and targeted therapyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As one of the post-translational modifications,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.